HIGHLIGHTS
- who: Seong Jun Jo and collaborators from the Integrated Research Institute of Pharmaceutical Sciences, College of Pharmacy, The Catholic University of Korea, Bucheon, Republic of Korea have published the paper: Clinical Pharmacokinetics of Approved RNA Therapeutics, in the Journal: (JOURNAL)
- what: The development of RNA therapeutics has advanced significantly over the last decade, resulting in the recent approval of several new drugs by the FDA and/or European Medicines Agency (EMA).
- how: The results showed that givosiran had little to no impact on the activity of CYP2C9 weakly reduced the activity of CYP3A4 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.